Mediwelcome Healthcare Management & Technology, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
7.00
-48.00
-106.00
-105.00
6.00
25.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2.00
0.00
-24.00
49.00
-33.00
-6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3.00
-15.00
-83.00
-22.00
0.00
34.00
Cash Flow from Investing Activities
-14.00
0.00
17.00
-10.00
-21.00
-12.00
Cash Flow from Financing Activities
41.00
6.00
1.00
1.00
113.00
-4.00
Net Cash Inflow / Outflow
30.00
-9.00
-64.00
-31.00
92.00
17.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mediwelcome Healthcare Management & Technology, Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
7.57214217438537
-10.482
17.00
172.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2.59417990276852
39.053
-41.00
-106.64%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3.2112737007097
33.264
-30.00
-90.35%
Cash Flow from Investing Activities
-14.7831380663201
-21.831
7.00
32.28%
Cash Flow from Financing Activities
41.5719498465397
-5.868
46.00
808.45%
Net Cash Inflow / Outflow
30.0000854809293
5.551
25.00
440.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-0.014
0.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 120.67% vs 81.44% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
3.21
-15.53
120.67%






